China is the bigger Alzheimer Drugs market: $403 Mn against $91 Mn in 2023, about 4.4 times as large.
India grows faster: 9.8% a year, against 8.3%. The gap still grows from $312 Mn to $662 Mn by 2033.
Clinical research: 7 active trials in India, 148 in China.
| Measure |  India |  China |
|---|---|---|
| Market size, 2023 | $91 Mn | $403 Mn |
| Market size, 2033 projected | $232 Mn | $894 Mn |
| Growth a year (CAGR) | 9.8% | 8.3% |
| Money added, 2023–2033 | $141 Mn | $491 Mn |
| Size rank of 24 countries | #13 | #3 |
| Market per person, 2023 | $0.06 | $0.29 |
| Active clinical trials | 7 | 148 |
| Full report | India report | China report |
Year by year, 2023 to 2033
India China · values between 2023 and 2033 are projected from the 2023 size and the CAGR.
Quick answers
Which is bigger in Alzheimer Drugs, India or China?
China is the bigger Alzheimer Drugs market: $403 Mn against $91 Mn in 2023, about 4.4 times as large.
Which grows faster in Alzheimer Drugs, India or China?
India grows faster: 9.8% a year, against 8.3%. The gap still grows from $312 Mn to $662 Mn by 2033.
More Alzheimer Drugs comparisons
Sources: market size and growth: Acuitas Health Analytics research (2023 base year, forecasts to 2033). Trials: ClinicalTrials.gov (fetched 10 Nov 2026); found by search words, so counts are a guide. Population: World Bank.